Code of Conduct Interfarma Review 2012

Transcription

1 Code of Conduct Interfarma Review 2012 Segundo Congreso Latinoamericano de Compliance de la Industria Farmacéutica e Insumos para la Salud, y el Foro de Buenas Prácticas

2

3 Interfarma has a cooperation agreement between the partners listed below Federal Council of Medicine Brazilian Medical Association Brazilian Society of Cardiology Signed a partnership with Interfarma - Code of Conduct Brazilian Association of distributors of special and exceptional medicines Brazilian Society of Pharmaceutical Medicine Oncoguia institute

4 IFPMA Code of Practice was established INTERFARMA Interfarma s Code of Conduct was written based on IFPMA s Code of Practice INTERFARMA The Agreement s content becomes part of the new Code IFPMA was established International Federation of Pharmaceutical Manufacturers & Associations INTERFARMA was founded Brazilian Research-based Pharmaceutical Manufactures Association INTERFARMA Code of Conduct first review

5 CODE DISSEMINATION TRAINING CERTIFICATION 2012 PROMOTION COMMUNICATION AND PUBLICITY MOBILIZATION AWARENESS AND RECOGNITION INTERFARMA 4 MODULES TRAINING INDUSTRY CUSTOM METHODOLOGY

6 CAUSE GUIDELINES FOR GOOD RELATIONSHIP PRACTICES WITH THE BRAZILIAN MEDICAL COMMUNITY, PUBLIC OFFICIALS, PACIENT ASSOCIATIONS, INSTITUTIONS, AND COMPANIES OF THE SECTOR EFFECT COMPLETED CERTIFICATION PROCESS IDENTIFIER BIOME 53 ASSOCIATED COMPANIES

7 AGREEMENTS FOR THE CODE OF CONDUCT: IT IS NOT THE END OF THE PROCESS IT IS JUST THE BEGINNING.

8 STRUCTURE OF THE CODE

9 GENERAL RULES FOR THE PHARMACEUTICAL SECTOR SECTION 1 FUNDAMENTAL PRINCIPLES SECTION 2 RELATIONSHIP WITH PUBLIC OFFICIALS AND GOVERNMENT AUTHORITIES SECTION 3 INTERACTIONS AND RELATIONSHIP WITH PACIENT ASSOCIATIONS SECTION 4 ADHENCE TO THE CODE AND ENFORCEMENT IN HEALTHCARE RELATED AREAS SECTION 5 CONTRACTING OF SPECIALIZED SERVICES IN HEALTHCARE SECTION 6 CONGRESS, SYMPOSIUMS, SEMINARS AND OTHER EVENTS SECTION 7 PROMOCIONAL MATERIALS SECTION 8 DRUG-RELATED ACTIVITIES AT POINTS OF SALES SECTION 9 COMMUNICATION ON NEW DRUGS AND INDICATIONS NOT APPROVED BY ANVISA (OFF LABEL) SECTION 10 OFFER OF GIFTS RULES RELATED TO DRUGS SUBJECT TO A PHYSICIAN S PRESCRIPTION SECTION 11 DISTRIBUTION OF FREE SAMPLES SECTION 12 VISIT TO HEALTHECARE PROFESSIONALS SECTION 13 DONATIONS AND OTHER CONTRIBUTION FOR HEALTHCARE INSTITUTIONS, BODIES, ASSOCIATIONS AND COMPANIES RULES RELATED TO OVER- THE-COUNTER DRUGS (OTC) SECTION 14 OVER-THE-COUNTER DRUGS (OTC) SECTION 15 DIRECT CONTACT WITH CONSUMERS SECTION 16 APPLICATION AND EFFECTIVENESS OF CODE OF CONDUCT RULES SECTION 17 ETHICS COMMITTEE SECTION 18 PENALTIES RULES FOR THE CONFLICT RESOLUTION

10 CODE OF CONDUCT - REVIEW 2012

11 This notice was published in the Onco & journal, Pharma Up magazine, Brazilian Society of Cardiology journal, AMB Journal and in the SNIF Doctor website. Was distributed to approximately doctors

12 CODE OF CONDUCT: THE CAMPAIGN I FOLLOW IT EXCEEDS 20 MIL CERTIFICATES employees of member companies have completed the training. The following companies have already completed the training: ABBOTT, ACTELION, ALEXION, ALLERGAN, AMGEN, ASTELLAS, ASTRAZENECA, BAGO, BAYER, BAXTER, BESINS, BIOGEN IDEC, BIOMARIN, BMS, BOEHRINGER, CELGENE, CHIESI, DAIICHI SANKYO, FERRING, GALDERMA, GE HEALTHCARE, GENZYME, GLAXOSMITHKLINE, GRUNENTHAL, IPSEN, ISDIN, JANSSEN, LEO PHARMA S.A., LILLY, LUNDBECK, MERCK S.A, MSD, MUNDIPHARMA, NOVARTIS, NOVO NORDISK, PFIZER, PIERRE FABRE, ROCHE, SANOFI, SERVIER, SHIRE, STIEFEL (GLAXOSMITHKLINE), TAKEDA, THERASKIN, ZAMBON. Link for access to the training: Link to access Interfarma s website : Webmeeting covered 58 different cities 60% of the participants were sales reps

13 August 19: webmeeting with doctors, with the presence of Dr. Florentino Cardoso 805 people have already seen Interfarma s webmeetings The number of accesses to the live encounter was around 295 hits of 113 cities and 20 different states, and there was an access from Mexico. Like the last, about 60% of the participants consisted of the sales force teams. The medical interest was about 24%, and 8% and 7% of pharmaceuticals associated or not to other industry fields. In addition, 22 questions about the Code of Conduct and the relationship between the pharmaceutical industry and the medical classes were asked and answered during the meeting. Número do WebMeeting: W12834 Senha para acesso: WR6A4 Or visit and enter the information above

14 CODE OF CONDUCT: I FOLLOW IT DAY

15 THANK YOU! MARIA JOSÉ DELGADO FAGUNDES DIRECTOR The images contained in here are restricted to this presentation